WASHINGTON — Federal health regulators have found tiny particles of trash in drugs made by Genzyme, the second time this year the biotechnology company has been cited for contamination issues.The FDA has an annual budget of $3.2 billion, plus Cato's estimated societal cost of $49 billion, and it can't even keep garbage out of our medicine.
The Food and Drug Administration said Friday that bits of steel, rubber and fiber found in vials of drugs used to treat rare enzyme disorders could cause serious adverse health effects for patients.
Despite those problems, the FDA said the products would remain on the market, because there are few alternative treatments.
What are we paying for exactly?
Posts
No comments:
Post a Comment